A few things that we shared recency

a) Vwap Guide : https://t.co/OZOom4RrLx
b) RSi Guide : https://t.co/aL5nNHSoPq
c) 786 MF Guide : https://t.co/612qeG976s
d) 4381 Companies data : https://t.co/Y8tesKmGN6
e) 920 Straddle data for 2021:

Twitter has 1000 dm per day message limit, so i miss out sending via DM if limit is crossed.

But i also post them online after sometime.

My past experience tells me to turn cautions on any asset class, the moment #GOLDMANSACHS gives incremental target when , it has already run towards extreme
As #GS sees #CrudeOil at 140 , I rein in my one-way Bullish optimism, I have been bullish since 40s-60s, 120 now
#OOTT

Prices fall, then, margins/topline takes beating, then, rerating normalizes, then, market loses interest, derating happens.Nothing excites - topline/margin. Market does not find quock triggers. Value emerges. Oneday triggers come, prices rise, growth comes, rerating happens

A durable market bottom will be formed at:
Peak Interest rates
Peak US Dollar
Peak Inflation.
Sentiment has to move to expectations of poor economic outlook, falling inflation and imminent rate cuts by central banks to support the economy .
Still some way off.

Many mid and small cap stocks are in correction phase. Watch 39 EMA closely many will take support from there and bounce back.

*Focus on Good Fundamental Stocks.
*Avoid stocks which go through lower circuit in last few days.
*keep tight stoploss below 55 EMA.

Stan Weinstein's Ideal Short Sale areas:

Most important candlestick patterns for stock selection:
Candlesticks are very good representation of psychology of traders in the market and hence the success rate of candlesticks pattern is very high.

New Combo using @mystockedge

Stocks with low PEG ratio
High ROE
Strong Price Action

https://t.co/ld4AiwlHOd https://t.co/ED7xFBgTiS

Simple trading system on such a Gap down day.
"5 Minute t/f"
with #supertrend
In this ocean, all kinds survive.
Only the egotist come out & yaps all day, how he/ she is the best.
Come to Madurai market & see the beehive of activity.
Everyone minds their own business
"Make Money"

Since many of you'll asked..
I love gapups upon results..I find them v powerful tools esp if they don't get filled over the first 3-5 days.
On the flip side..gapdown breakdowns are something i totally dislike..so i prefer to watch and watch...
DN, Tata Chem, Balaji

This is what a gapup breakout can potentially do..
Tesla's 10-20x move also started with a Gapup...

and before you'll start thinking gaps lead to multi bag moves..do remember..Tesla had fallen 60% before it started its move..
Most of our stocks currently already trading at rich valuations.

And lastly while on the subject of gaps..here is one which did gapdown on high volumes..
One of my biggest winners of 2020..
Never covered the gap and drifted downwards..

Just doing this as hindsight analysis to show visual examples of gapups and downs.

What is #Trendindicator ?
Technical Analysis with "Macd"

Do back test on index & stocks in #Tradingview chart using MACD, how your trading positions would have been on the right side!

https://t.co/I2n6qX4TL2

Spend just 15-30 minutes to learn a skill
with 100% focus & attention

The Q4F22 Earnings season is almost here!

What are the Key things that you need to track in various businesses like Hospitals 🏥, Pharma🩹, Chemicals 🧪 and Music🎵 etc ⤵️⤵️

I will be analysing the companies and the expectations in two ways:-

1⃣What does the company do and the sales split?
2⃣What to expect from the results/Business direction?

1. Divis Labs:

Over the years Divis has proven its capabilities as an API player and has the highest Ebitda margins (44%) when compared to the other Pharma companies. 57% of the business in the last Quarter Q3FY22 was contributed by Synthesis and 43% by Generic API’s.

What to expect?

Molnupiravir has contributed to almost 21% of sales for Divis in FY22 (According to Kotak).
Investors will need to track the recovery in the Generic API division which has been soft for the last 3 quarters and growth in CDMO ex of Molnupiravir.

What to look for in Financials?

Key monitorable to track is by how much the topline grows or degrows QoQ. Given the base was high in last Quarter due to Molnupiravir Sales.

Topline sustaining above 2100 crores and margins above 41% will be good!